Cargando…

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells

The immune regulator galectin-9 (Gal-9) is commonly involved in the regulation of cell proliferation, but with various impacts depending on the cell type. Here, we revealed that Gal-9 expression was persistently increased in Epstein-Barr virus (EBV)-infected primary B cells from the stage of early i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jing-xiao, Zhang, Rong, Huang, Dai-jia, Tang, Ying, Ping, Li-qin, Huang, Bi-jun, Huang, Hui-qiang, Busson, Pierre, Li, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927364/ https://www.ncbi.nlm.nih.gov/pubmed/36622166 http://dx.doi.org/10.1128/spectrum.04932-22

Ejemplares similares

Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
por: Chen, Kui, et al.
Publicado: (2012)

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection
por: Petrara, Maria R., et al.
Publicado: (2013)

Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for Lymphomagenesis in Children
por: Vistarop, Aldana, et al.
Publicado: (2020)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
por: Kelly, Gemma L., et al.
Publicado: (2009)

Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
por: Zhang, Chuan-xia, et al.
Publicado: (2020)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma
por: Li, Binbin, et al.
Publicado: (2013)

Correction to: Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
por: Zhang, Chuan-xia, et al.
Publicado: (2022)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
por: Chen, Ruyue, et al.
Publicado: (2023)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis
por: Song, Chen-Ge, et al.
Publicado: (2015)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells
por: Yajima, Misako, et al.
Publicado: (2018)

Cardiovascular involvement in Epstein–Barr virus infection
por: Chen, Xinying, et al.
Publicado: (2023)

Immunosenescence and lymphomagenesis
por: Mancuso, Salvatrice, et al.
Publicado: (2018)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
por: Keryer-Bibens, Cécile, et al.
Publicado: (2006)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Correlation of nasopharyngeal carcinoma with rare earth elements and the Epstein-Barr virus
por: Zhang, Xiangmin, et al.
Publicado: (2018)

Epstein-Barr virus infection: the micro and macro worlds
por: Huang, Wei, et al.
Publicado: (2023)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis
por: Zhang, Yunyun, et al.
Publicado: (2023)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
por: Wu, Chung-Chun, et al.
Publicado: (2017)

Spontaneous metastases in immunocompetent mice harboring a primary tumor driven by oncogene latent membrane protein 1 from Epstein–Barr virus
por: Chang, Pu-Yuan, et al.
Publicado: (2016)

Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal Carcinoma
por: Sheen, Tzung‐Shiahn, et al.
Publicado: (1999)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

Virus-Associated Lymphomagenesis
por: Tarantul, V. Z.
Publicado: (2006)

A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan
por: Chen, Chao-Yu, et al.
Publicado: (2015)

Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein–Barr virus: Two cases report
por: Ling, Wenwu, et al.
Publicado: (2019)

Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas
por: Zhang, Yi-wang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3nncvaemllceh5chpekdjj70f2